Early antiretroviral therapy initiation in west Africa has no adverse social consequences: A 24-month prospective study

AIDS

Volumn 30, Issue 10, 2016, Pages 1677-1680

  Jean, Kévin ^a   Niangoran, Serge ^b   Danel, Christine ^b,c   Moh, Raoul ^b,d   Kouamé, Gérard Menan ^b   Badjé, Anani ^b   Gabillard, Delphine ^b,c   Eholié, Serge ^b   Dray Spira, Rosemary ^e,f   Lert, France ^g,h   Anglaret, Xavier ^b,c   Desgrées Du Loû, Annabel ⁱ  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UFR Sciences Médicales Université Félix   (France)

^e INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ Université Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COTE D'IVOIRE; DRUG THERAPY; EARLY INTERVENTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MENTAL HEALTH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIAL DISCRIMINATION; SOCIAL SUPPORT; VIRUS LOAD; AFRICA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; PROCEDURES; PROSPECTIVE STUDY; SECONDARY PREVENTION; SOCIAL DISTANCE;

ANTIRETROVIRUS AGENT;

AFRICA, WESTERN; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; SECONDARY PREVENTION; SOCIAL DISTANCE;

EID: 84961392759     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001100     Document Type: Article

References (21)

1. TEMPRANO ANRS 12136 Study Group. Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015; 373:808-822.
2. INSIGHT START Study Group. Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015; 373:795-807.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
4. Vu L, Andrinopoulos K, Mathews C, Chopra M, Kendall C, Eisele TP. Disclosure of HIV status to sex partners among HIVinfected men and women in Cape Town, South Africa. AIDS Behav 2012; 16:132-138.
5. Linda P. To tell or not to tell: negotiating disclosure for people living with HIV on antiretroviral treatment in a South African setting. SAHARA J 2013; 10 (Suppl 1):S17-S27; J Soc Asp HIVAIDS Res Alliance SAHARA Hum Sci Res Counc.
6. Haberlen SA, Nakigozi G, Gray RH, Brahmbhatt H, Ssekasanvu J, Serwadda D, et al. Antiretroviral therapy availability and HIV disclosure to spouse in Rakai, Uganda: a longitudinal population- based study. JAIDS J Acquir Immune Defic Syndr 2015; 69:241-247.
7. Tijou Traoré A, Querre M, Brou H, Leroy V, Desclaux A, Desgrées-du-Loû A. Couples, PMTCT programs and infant feeding decision-making in Ivory Coast. Soc Sci Med 2009; 1982:2009; 69:830-837.
8. Henry E, Bernier A, Lazar F, Matamba G, Loukid M, Bonifaz C, et al. Was it a mistake to tell others that you are infected with HIV': factors associated with regret following HIV disclosure among people living with HIV in five countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a community-based research. AIDS Behav 2014; doi: 10.1007/s10461-014-0976-8; Published Online First.
9. Pearson CR, Micek MA, Pfeiffer J, Montoya P, Matediane E, Jonasse T, et al. One year after ART initiation: psychosocial factors associated with stigma among HIV-positive mozambicans. AIDS Behav 2009; 13:1189-1196.
10. Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma' The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect 2009; 85:308-312.
11. Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, et al. How does antiretroviral treatment attenuate the stigma of HIV' Evidence from a cohort study in rural Uganda. AIDS Behav 2013; 17:2725-2731.
12. Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One 2010; 5:; doi:10.1371/jour nal.pone.0012731.
13. Bor J, Tanser F, Newell M-L, Bärnighausen T. In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) 2012; 31:1459-1469.
14. WHO. Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva, Switzerland: WHO; 2015:; http://www.who.int/entity/hiv/pub/guidelines/earlyrele ase-arv/en/ (accessed 6 Oct2015).
15. Jean K, Gabillard D, Moh R, Danel C, Desgrées-du-Loû A, N'takpe J-B, et al. Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire. J Int AIDS Soc 2014; 17:18977.
16. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2006 revision. Geneva: World Health Organisation; 2006; http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf.
17. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. Geneva: World Health Organisation; 2010; http://www.who.int/hiv/pub/arv/adult2010/en/index.html (accessed 6 Mar2013).
18. Katz IT, Essien T, Marinda ET, Gray GE, BangsbergDR, Martinson NA, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS Lond Engl 2011; 25:2177-2181.
19. Katz IT, Dietrich J, Tshabalala G, Essien T, Rough K, Wright AA, et al. Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav 2014 ; doi:10.1007/s10461-014-0920-y; Published Online First.
20. Ouattara E, Danel C, Moh R, Gabillard D, Peytavin G, Konan R, et al. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in west African adults with high CD4 counts. J Int AIDS Soc 2013; 16:18059.
21. Jean K, Gabillard D, Moh R, Danel C, Fassassi R, Desgrées-du- Loû A, et al. Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Cô te d'Ivoire. J Infect Dis 2014; 209:431-440.